Viewing Study NCT00506805


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-02-13 @ 4:08 PM
Study NCT ID: NCT00506805
Status: COMPLETED
Last Update Posted: 2012-05-28
First Post: 2007-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies
Sponsor: Esanex Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module